Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-12-22
1980-08-12
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544295, 544336, 544405, 544408, 544337, 544332, 544331, 544329, 544328, 544319, 544316, 544296, 544238, 424258, 424251, 424267, 546194, 546201, 546210, 546141, 546143, 546162, 546153, 546265, 546273, 546278, A61K 31495, C07D40114
Patent
active
042173507
ABSTRACT:
A process known per se for the manufacture of oxygenated N-aryl-diazacyclic compounds of the formula ##STR1## wherein each of R.sub.1 and R.sub.2 represents a substituted or unsubstituted aryl group and alk represents a lower alkylene group which separates both nitrogen atoms from each other by 2 or 3 carbon atoms, or salts thereof.
The novel compounds can be used as antihypertensives, antitachycardiac agents and .alpha.-receptor blockers.
REFERENCES:
patent: 4144344 (1979-03-01), Eichenberger et al.
Eichenberger Kurt
Kuhnis Hans
Ostermayer Franz
Schroter Herbert
Bond Robert T.
Ciba-Geigy Corporation
Ford John M.
Maitner John J.
LandOfFree
Oxygenated N-aryl-diazacyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxygenated N-aryl-diazacyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxygenated N-aryl-diazacyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2182529